Externalized Keratin 8: A Target at the Interface of Microenvironment and Intracellular Signaling in Colorectal Cancer Cells

Archive ouverte

Albaret, Marie Alexandra | Vermot-Desroches, Claudine | Paré, Arnaud | Roca-Martinez, Jean-Xavier | Malet, Lucie | Esseily, Jad | Gerossier, Laetitia | Brière, Johan | Pion, Nathalie | Marcel, Virginie | Catez, Frédéric | de Souza, Geneviève | Vuillermoz, Boris | Doerflinger, Franck | Lavocat, Emilie | Subiger, Olivier | Rousset, Carine | Bresson, Corinne | Mandon, Elodie | Jawhari, Anass | Falson, Pierre | Jasmin, Mélissa | Couté, Yohann | Mertani, Hichem | Saintigny, Pierre | Diaz, Jean-Jacques

Edité par CCSD ; MDPI -

International audience. Accumulating evidence supports the remarkable presence at the membrane surface of cancer cells of proteins, which are normally expressed in the intracellular compartment. Although these proteins, referred to as externalized proteins, represent a highly promising source of accessible and druggable targets for cancer therapy, the mechanisms via which they impact cancer biology remain largely unexplored. The aim of this study was to expose an externalized form of cytokeratin 8 (eK8) as a key player of colorectal tumorigenesis and characterize its mode of action. To achieve this, we generated a unique antagonist monoclonal antibody (D-A10 MAb) targeting an eight-amino-acid-long domain of eK8, which enabled us to ascertain the pro-tumoral activity of eK8 in both KRAS-mutant and wild-type colorectal cancers (CRC). We showed that this pro-tumoral activity involves a bidirectional eK8-dependent control of caspase-mediated apoptosis in vivo and of the plasminogen-induced invasion process in cellulo. Furthermore, we demonstrated that eK8 is anchored at the plasma membrane supporting this dual function. We, therefore, identified eK8 Cancers 2018, 10, 452 2 of 17 as an innovative therapeutic target in CRC and provided a unique MAb targeting eK8 that displays anti-neoplastic activities that could be useful to treat CRC, including those harboring KRAS mutations.

Suggestions

Du même auteur

Combined proteomic and transcriptomic approaches reveal externalized keratin 8 as a potential therapeutic target involved in invasiveness of head and neck cancers

Archive ouverte | Albaret, Marie Alexandra | CCSD

International audience. Keratin 8 (K8) expressed at the surface of cancer cells, referred as externalized K8 (eK8), has been observed in a variety of carcinoma cell lines. K8 has been previously reported to be expre...

Spatial sequestration of activated-caspase 3 in aggresomes mediates resistance of neuroblastoma cell to bortezomib treatment

Archive ouverte | Berthenet, Kévin | CCSD

International audience. Neuroblastoma (NB) is the most common pediatric tumor and is currently treated by several types of therapies including chemotherapies, such as bortezomib treatment. However, resistance to bor...

Uncoupling ribosome biogenesis regulation from RNA polymerase I activity during herpes simplex virus type 1 infection.

Archive ouverte | Belin, Stéphane | CCSD

International audience. The ribosome is the central effector of protein synthesis, and its synthesis is intimately coordinated with that of proteins. At present, the most documented way to modulate ribosome biogenes...

Chargement des enrichissements...